Table 2.
Primary outcome: changes within groups and differences between groups at month 24 (M24) in the proportion of patients achieving all their therapeutic targets
| Endpoint | Group | M0 n/N (%) | M24 n/N (%) | OR (95% CI) for within group comparison | P | OR (95% CI) for between group comparison | P-value |
|---|---|---|---|---|---|---|---|
| All patients (3 or 5 targets) |
Intervention |
56/900 (6.2) |
110/860 (12.8) |
3.23 (2.12 to 4.94) |
< 0.001 |
1.89 (1.09 to 3.27) |
0.024 |
| Usual care |
94/923 (10.2) |
118/860 (13.7) |
1.71 (1.19 to 2.47) |
0.004 |
|||
| Hypertension + T2D (5 targets) |
Intervention |
7/527 (1.3) |
24/526 (4.6) |
3.90 (1.60 to 9.52) |
0.003 |
2.36 (0.68 to 8.18) |
0.175 |
| Usual care |
9/520 (1.7) |
14/513 (2.7) |
1.65 (0.69 to 3.98) |
0.262 |
|||
| Hypertension (3 targets) |
Intervention |
49/373 (13.1) |
86/334 (25.8) |
3.12 (1.94 to 5.03) |
< 0.001 |
1.63 (0.99 to 3.01) |
0.120 |
| Usual care | 85/403 (21.1) | 104/347 (29.0) | 1.91 (1.27 to 2.88) | 0.002 |
CI, confidence interval; M0, month 0; M24, month 24; T2D, type-2 diabetes; OR, odds-ratio.